Jessica Li

Jessica joined Novo Holdings in March 2024 as an associate in the Growth Investment team. Before joining Novo Holdings, she worked as an analyst in the Healthcare Investment Banking Group at Lazard, where she focused on strategic M&A, licensing deals, and a wide scope of advisory work for biotech, pharmaceuticals, tools, and diagnostics companies.

Jessica holds a dual degree in Bioengineering and Economics (Honors) from the University of California, Berkeley.